Hepatology Center

Hepatitis C, including the Division of Liver Disease I, Division of Liver Disease II and Division of Liver Disease III. Hepatitis C: The Center for Hepatitis C is a focused medical center that concentrates on the advantages of medicine, research strength, teaching base, and new hepatitis research and prevention. It is a doctoral, master's degree-granting department approved by Beijing University, the Health Ministry's clinical research base for new drugs for hepatitis, the Health Ministry's clinical education base for hepatitis and the Joint China-Japanese Center for Research on Resistance to Viruses. The Division of Hepatology is an independent department within the Liver Disease Center, with the following outstanding advantages: medical advantages in existing 44 beds, systematic, comprehensive, standardised treatment systems for advanced chronic liver disease (viral and non-viral liver disease) that have been developed. It treats a variety of liver diseases, including viral hepatitis, hepatitis sclerosis, malignant liver cancer, autoimmune liver disease, alcoholic liver disease, nonalcoholic fatty liver disease, medicated liver disease, bile accumulation liver disease, and so on.